45 related articles for article (PubMed ID: 17715114)
1. Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm.
Gao J; Han F; Wang X; Duan S; Zhang J
Front Oncol; 2021; 11():699812. PubMed ID: 34926238
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of Pancreatic Serous Cystadenomas From Mucinous Cystadenomas With CT Textural Features: Based on Machine Learning.
Yang J; Guo X; Ou X; Zhang W; Ma X
Front Oncol; 2019; 9():494. PubMed ID: 31245294
[No Abstract] [Full Text] [Related]
3. Imaging modalities for characterising focal pancreatic lesions.
Best LM; Rawji V; Pereira SP; Davidson BR; Gurusamy KS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010213. PubMed ID: 28415140
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
[TBL] [Abstract][Full Text] [Related]
5. Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution.
Manfredi R; Bonatti M; D'Onofrio M; Mehrabi S; Salvia R; Mantovani W; Pozzi Mucelli R
Radiol Med; 2013 Mar; 118(2):163-80. PubMed ID: 22744342
[TBL] [Abstract][Full Text] [Related]
6. Imaging of benign and malignant cystic pancreatic lesions and a strategy for follow up.
Bhosale P; Balachandran A; Tamm E
World J Radiol; 2010 Sep; 2(9):345-53. PubMed ID: 21160696
[TBL] [Abstract][Full Text] [Related]
7. Imaging spectrum of cystic pancreatic lesions: learn from atypical cases.
Irie H; Yoshimitsu K; Tajima T; Asayama Y; Hirakawa M; Ishigami K; Ushijima Y; Honda H
Curr Probl Diagn Radiol; 2007; 36(5):213-26. PubMed ID: 17765800
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI.
Visser BC; Yeh BM; Qayyum A; Way LW; McCulloch CE; Coakley FV
AJR Am J Roentgenol; 2007 Sep; 189(3):648-56. PubMed ID: 17715113
[TBL] [Abstract][Full Text] [Related]
9. Management of cystic pancreatic masses.
Op de Beeck B; Spinhoven M; Corthouts B; de Jongh K; Salgado R; Parizel P
JBR-BTR; 2007; 90(6):482-6. PubMed ID: 18376760
[TBL] [Abstract][Full Text] [Related]
10. Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings.
Hattori Y; Gabata T; Zen Y; Mochizuki K; Kitagawa H; Matsui O
Pancreas; 2010 Nov; 39(8):1263-70. PubMed ID: 20467344
[TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
12. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions.
Lee HJ; Kim MJ; Choi JY; Hong HS; Kim KA
Clin Radiol; 2011 Apr; 66(4):315-21. PubMed ID: 21356393
[TBL] [Abstract][Full Text] [Related]
13. Relative accuracy of CT and MRI for characterization of cystic pancreatic masses.
Katz DS; Friedel DM; Kho D; Georgiou N; Hines JJ
AJR Am J Roentgenol; 2007 Sep; 189(3):657-61. PubMed ID: 17715114
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
